Novavax
NVAX
#5699
Rank
$1.31 B
Marketcap
$7.96
Share price
-1.24%
Change (1 day)
17.06%
Change (1 year)

Novavax (NVAX) - P/B ratio

P/B ratio as of November 2026 : -6.89

According to Novavax's latest financial reports the company has a price-to-book ratio of 3.1742.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novavax - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-31-9.07326.57%
2024-12-31-2.13167.32%
2023-12-31-0.7953-42.29%
2022-12-31-1.38-95.52%
2021-12-31-30.8-371.78%
2020-12-3111.3-1735.05%
2019-12-31-0.6922-83.57%
2018-12-31-4.21-7.94%
2017-12-31-4.58-92.57%
2016-12-31-61.6-896.25%
2015-12-317.7425.48%
2014-12-316.1717.34%
2013-12-315.2650.85%
2012-12-313.4829.53%
2011-12-312.69-41.12%
2010-12-314.5719.85%
2009-12-313.8132.66%
2008-12-312.87-12.14%
2007-12-313.2721.37%
2006-12-312.70-36.5%
2005-12-314.249.54%
2004-12-313.87-33.15%
2003-12-315.80-27.94%
2002-12-318.04

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
8.00-216.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.90-127.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.61-181.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
4.05-158.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
1.04-115.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.08-144.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-1.36-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
3.41-149.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-4.25-38.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.8449-112.27%๐Ÿ‡บ๐Ÿ‡ธ USA